|
Market Cap (21-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 31 August 2021, 8:15. The announcement is marked as price sensitive, and is 3 page(s) in length and 80.88kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.017% short sold according to ASIC data. It was ranked the 544th most shorted stock on the ASX. It remains ranked 544th as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Appendix 4E | 31 August 2021, 8:15 |
| Annual Report to shareholders | 31 August 2021, 8:12 |
| MDC Receives Approval for NanaBis PIII Trials from the TGA | 25 August 2021, 9:15 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 30 July 2021, 10:06 |
You must be logged in to post a reply.
Medlab Clinical 